A detailed history of Chapin Davis, Inc. transactions in Dyadic International Inc stock. As of the latest transaction made, Chapin Davis, Inc. holds 826,301 shares of DYAI stock, worth $1.28 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares
826,301
Previous 826,301 -0.0%
Holding current value
$1.28 Million
Previous $1.33 Billion 3.73%
% of portfolio
0.5%
Previous 0.56%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 11, 2024

SELL
$1.52 - $2.04 $18,240 - $24,480
-12,000 Reduced 1.43%
826,301 $1.33 Billion
Q3 2023

Oct 19, 2023

BUY
$1.71 - $2.08 $10,260 - $12,480
6,000 Added 0.72%
838,301 $1.61 Billion
Q2 2023

Aug 30, 2023

BUY
$1.56 - $2.38 $14,040 - $21,420
9,000 Added 1.09%
832,301 $1.61 Billion
Q1 2023

Apr 12, 2023

BUY
$1.25 - $1.86 $4,590 - $6,829
3,672 Added 0.45%
823,301 $1.47 Billion
Q4 2022

Jan 27, 2023

BUY
$1.18 - $2.29 $967,162 - $1.88 Million
819,629 New
819,629 $1.01 Billion

Others Institutions Holding DYAI

About DYADIC INTERNATIONAL INC


  • Ticker DYAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,423,100
  • Market Cap $44.1M
  • Description
  • Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vac...
More about DYAI
Track This Portfolio

Track Chapin Davis, Inc. Portfolio

Follow Chapin Davis, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chapin Davis, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Chapin Davis, Inc. with notifications on news.